Mercury Laboratories Ltd

NSE: MERCURYLAB · BSE: 538964 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹765.00
Market cap: ₹91.80 Cr
Revenue (annual): ₹75.94 Cr
Net profit (annual): ₹4.83 Cr
P/E (TTM): 22.1×Sector 47.4×
Promoter holding: 73.66%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 5 Other Announcement 4 Financial Results 3 Debt & Borrowing 2 Board Meeting Date 2 Results Correction 1 Dividend 1 Credit Rating 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 Apr 2026 12:06 IST BSE

Debt & Borrowing

Mercury Laboratories Debt & Borrowing

Mercury Laboratories Ltd submitted its annual disclosure for FY 2025-26 under the SEBI Large Corporate framework. The company confirmed it was not identified as a Large Corporate (LC) for the period, resulting in nil mandatory borrowing requirements through debt securities and no applicable penalties.

Read the filing ↗

29 Apr 2026 11:49 IST BSE

Debt & Borrowing

Mercury Laboratories Debt & Borrowing: ₹7.31 Cr

Mercury Laboratories Ltd disclosed an outstanding borrowing of ₹7.31 Crore as of March 31, 2026. Under SEBI's Large Corporate framework, the company confirmed its status and reported a BB+/Stable credit rating from CRISIL Limited.

Value: ₹7.31 Cr

Read the filing ↗